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Background:   
Iron deposition in cardiomyocytes in primary or secondary haemochromatosis can result in the 
development of dilated cardiomyopathy and heart failure. 
Case presentation:   
A 63-year-old man has been admitted to the Noninvasive Cardiology Unit due to exacerbation of  
chronic heart failure with reduced ejection fraction (HFrEF). The patient was previously hospitalized 10 
months ago for the same reason. His history included non-ischaemic dilated cardiomyopathy 
diagnosed at the age of 58 (no atherosclerotic lesions were found in coronary angiography), insulin-
dependent diabetes mellitus, hypercholesterolemia and two-time pulmonary oedema (in 2016 and 
2018). ECG at admission showed atrial fibrillation with rapid ventricular action and single ventricular 
extrasystoles. Echocardiography revealed atrial and left ventricular enlargement, systolic dysfunction 
of both ventricles, EF=23%, TAPSE=15mm, mild tricuspid regurgitation with medium probability of 
pulmonary hypertension. In laboratory tests ferritin level was 647.4 ng/ml and TSAT=42.9%. 
Abdominal ultrasound did not reveal any abnormalities. Due to high levels of ferritin and non-
ischaemic background of dilated cardiomyopathy, the haemochromatosis was suspected and cardiac 
magnetic resonance (CMR) and genetic test for HFE gene mutation was ordered. The CMR confirmed 
reduced left ventricular systolic function with EF=20%, but without myocardial hypertrophy, and 
revealed left ventricular fibrosis of non-ischemic etiology. On the other hand, genetic testing showed 
heterozygotic mutation of C282Y in the HFE gene. According to the diagnostic algorithm for 
haemochromatosis from 2011 AASLD guidelines, the primary haemochromatosis diagnosis was 
rejected. The overlap of non-genetic causes of secondary siderosis with the carrier state of the 
pathogenic variant of the HFE gene was considered. The patient was referred for secondary siderosis 
causes diagnostics. 
Conclusion:   
Among the causes of heart failure with repeated hospitalizations per year, storage disorders should be 
considered. This is particularly relevant if coronary heart disease is excluded as the most common 
cause of HFrEF and if laboratory test results abnormalities coexist. 
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